APAC Non-Invasive Ventilators Market to Surge at an Estimated CAGR of 11.11% During 2025-30

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The APAC Non-Invasive Ventilators Market size was valued at around USD532 million in 2024 and is projected to reach USD903 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.11% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report.

The main reasons behind this market growth include an increase in air pollution, a rise in the aging population, standardized legislative guidelines, cost competitiveness of non-invasive ventilators, advancements in technology, regular investments in healthcare infrastructure, and others. The usage of ventilators reduces the risk of death from terminal diseases. Non-invasive ventilators provide oxygen support during the treatment of lung infections, surgeries, and other conditions. It reduces the load on the lungs for respiration, hence aiding in speedy recovery.

The air quality in Asian countries such as China, India, Bangladesh, etc., is deteriorating due to construction and poor implementation of environmental norms. Thus, its inhalation results in severe damage to the lungs. It is estimated that China and India together have more than 200 million patients suffering from acute respiratory illness. Thus, to provide life support, non-invasive ventilators are playing an anchor role.

Moreover, the expansion of the healthcare infrastructure is needed to accommodate the rising number of cases of diseases, including respiratory diseases. The infrastructure development and the enlargement of the healthcare units, such as hospitals and primary health units, require non-invasive ventilators. Additionally, government support and policies in the medical sector further promote the growth of the market. For instance, in 2022, China’s state council allotted USD29 billion for the upgradation of medical equipment. India also supported NIV technology with the development of Indigenous ventilators like “SwathVayu”, further stated in the research report, “APAC Non-Invasive Ventilators Market Analysis, 2025.”

Segmentation Analysis

Chronic Obstructive Pulmonary Disease Generating Maximum Market Demand

Based on the application, the market is further bifurcated into Chronic Obstructive Pulmonary Disease, Asthma, Respiratory Distress Syndrome, Pneumonia, Sleep Apnea, Resuscitation, Cardiogenic Pulmonary Edema, and others. Chronic obstructive pulmonary disease has the largest market share. This disease is caused due to the inhalation of polluted air, longer exposure to chemicals, smoking tobacco, etc. As a result, to mitigate the progressive damage, regular oxygen therapies are required. Thus, this increases the demand for ventilators among patients suffering from such diseases. Moreover, the advancements in non-invasive ventilators provide comfort to patients over invasive ventilators.

China Dominates Non-Invasive Ventilators Industry in APAC

China is leading the non-invasive ventilators market in the Asia-Pacific region with a market share of around 43%. This is due to the rise in the number of cases of respiratory diseases in the region. China has one of the largest industrial sectors worldwide. Therefore, the pollution from manufacturing and processing units is damaging the lungs of the individuals living in the cities and industrial areas.  This leads to an increase in respiratory tract infections and damaged lungs thereby increasing demand for ventilators in hospitals. 

Moreover, several government policies and schemes have been introduced in the healthcare industry in China to develop its medical infrastructure. For instance, in the economic stimulus package by the executive council of China, in September 2022, USD29 billion was allocated for the upgradation of existing medical facilities in China. Additionally, by way of a discounted loan policy, Chinese hospitals are encouraged to upgrade their medical equipment and develop advanced medical facilities.

These measures have led to increased usage of NIV (Non-invasive ventilation) in Chinese hospitals, specifically for diseases such as tuberculosis, SARS, H1N1, etc. Thus, these measures and government support in the form of discounted loans for medical infrastructure have further fueled demand for non-invasive ventilators in the country.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Teleflex Incorporated, Vyaire Medicals, Dragerwerk AG & Co., Medtronic plc, Philips, ResMed, Inc., O-Two Medical Technologies Inc., Dimar, Intersurgical Ltd., Vygon, Vapotherm, Inc., and others, are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the region?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across various countries?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?